SAFET+ Trademark

Trademark Overview

On Friday, January 19, 2018, a trademark application was filed for SAFET+ with the United States Patent and Trademark Office. The USPTO has given the SAFET+ trademark a serial number of 87762123. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 26, 2021. This trademark is owned by celledit LLC. The SAFET+ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cancer, infectious disease, immune related disease; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of cancer, infectious disease, immune related disease; Pharmaceutical preparations for cancer, infectious disease, immune related disease; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer, infectious disease, immune related disease
safet+

General Information

Serial Number87762123
Word MarkSAFET+
Filing DateFriday, January 19, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 26, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 30, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of cancer, infectious disease, immune related disease; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of cancer, infectious disease, immune related disease; Pharmaceutical preparations for cancer, infectious disease, immune related disease; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer, infectious disease, immune related disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 31, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party Namecelledit LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
Addressworcester, MA 01606
Party Namecelledit LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNewark, DE 19702

Trademark Events

Event DateEvent Description
Monday, July 26, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 26, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 14, 2020EXTENSION 4 GRANTED
Monday, December 14, 2020EXTENSION 4 FILED
Monday, December 14, 2020TEAS EXTENSION RECEIVED
Thursday, June 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 2, 2020EXTENSION 3 GRANTED
Tuesday, June 2, 2020EXTENSION 3 FILED
Tuesday, June 2, 2020TEAS EXTENSION RECEIVED
Thursday, December 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2019EXTENSION 2 GRANTED
Tuesday, December 17, 2019EXTENSION 2 FILED
Tuesday, December 17, 2019TEAS EXTENSION RECEIVED
Tuesday, June 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 22, 2019EXTENSION 1 GRANTED
Saturday, June 22, 2019EXTENSION 1 FILED
Saturday, June 22, 2019TEAS EXTENSION RECEIVED
Tuesday, December 25, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 30, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 30, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 10, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 18, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 18, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 18, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, September 15, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 15, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, September 15, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 15, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 1, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 1, 2018NON-FINAL ACTION E-MAILED
Tuesday, May 1, 2018NON-FINAL ACTION WRITTEN
Tuesday, May 1, 2018ASSIGNED TO EXAMINER
Thursday, March 22, 2018PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, March 20, 2018ASSIGNED TO LIE
Wednesday, March 7, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, January 31, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 23, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

safet pharmaceutical disease treatment infectious cancer related immune preparations diseases products